French health insurance data for chronic rhinosinusitis with nasal polyps between 2011 and 2018 : A STROBE-compliant analysis
Copyright © 2022 Elsevier Masson SAS. All rights reserved..
AIMS: The main aim of the present study was to report the annual volume of surgeries performed for chronic rhinosinusitis with nasal polyps (CRSwNP) in France, based on health insurance data. The secondary objectives were to describe the different characteristics of the surgeries and their complications, and to estimate the number of patients eligible for biotherapy.
MATERIAL AND METHODS: This was a descriptive observational retrospective study using data from French national health insurance databases for the period 2011-2018. Inclusion criteria comprised all hospital stays with procedures related to CRSwNP according to the French Common Classification of Medical Acts and consistent with French practices.
RESULTS: Ninety-two thousand one hundred and fourty one patients (92,141) for 92,884 admissions for CRSwNP surgery were analyzed, providing an accurate representation of CRSwNP surgery in France between 2011 and 2018. The revision surgery rate for patients operated on in 2011 was 13.0% (1,457/11,212), corresponding to an average annual rate of 1.86% over 7 years. In the 11,750 sinus surgery admissions in 2018, the complications rate was only 0.65% (77/11,750).
CONCLUSION: Sinus surgery is safe (0.65% complications) and reliable (estimated revision rate, 5.5%: 5,078/92,884). This study provides the first evaluation of the target population for biotherapy in France.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:140 |
|---|---|
| Enthalten in: |
European annals of otorhinolaryngology, head and neck diseases - 140(2023), 2 vom: 01. März, Seite 65-69 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fieux, M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Chronic rhinosinusitis with nasal polyps |
|---|
| Anmerkungen: |
Date Completed 20.03.2023 Date Revised 20.03.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.anorl.2022.08.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM345459032 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM345459032 | ||
| 003 | DE-627 | ||
| 005 | 20231226025112.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.anorl.2022.08.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1151.xml |
| 035 | |a (DE-627)NLM345459032 | ||
| 035 | |a (NLM)36028425 | ||
| 035 | |a (PII)S1879-7296(22)00089-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fieux, M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a French health insurance data for chronic rhinosinusitis with nasal polyps between 2011 and 2018 |b A STROBE-compliant analysis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.03.2023 | ||
| 500 | |a Date Revised 20.03.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a AIMS: The main aim of the present study was to report the annual volume of surgeries performed for chronic rhinosinusitis with nasal polyps (CRSwNP) in France, based on health insurance data. The secondary objectives were to describe the different characteristics of the surgeries and their complications, and to estimate the number of patients eligible for biotherapy | ||
| 520 | |a MATERIAL AND METHODS: This was a descriptive observational retrospective study using data from French national health insurance databases for the period 2011-2018. Inclusion criteria comprised all hospital stays with procedures related to CRSwNP according to the French Common Classification of Medical Acts and consistent with French practices | ||
| 520 | |a RESULTS: Ninety-two thousand one hundred and fourty one patients (92,141) for 92,884 admissions for CRSwNP surgery were analyzed, providing an accurate representation of CRSwNP surgery in France between 2011 and 2018. The revision surgery rate for patients operated on in 2011 was 13.0% (1,457/11,212), corresponding to an average annual rate of 1.86% over 7 years. In the 11,750 sinus surgery admissions in 2018, the complications rate was only 0.65% (77/11,750) | ||
| 520 | |a CONCLUSION: Sinus surgery is safe (0.65% complications) and reliable (estimated revision rate, 5.5%: 5,078/92,884). This study provides the first evaluation of the target population for biotherapy in France | ||
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Chronic rhinosinusitis with nasal polyps | |
| 650 | 4 | |a Complications | |
| 650 | 4 | |a Epidemiology | |
| 650 | 4 | |a Surgery | |
| 700 | 1 | |a Lisan, Q |e verfasserin |4 aut | |
| 700 | 1 | |a Nevoux, J |e verfasserin |4 aut | |
| 700 | 1 | |a Bartier, S |e verfasserin |4 aut | |
| 700 | 1 | |a Darnal, E |e verfasserin |4 aut | |
| 700 | 1 | |a Mahieu, A |e verfasserin |4 aut | |
| 700 | 1 | |a Karam, P |e verfasserin |4 aut | |
| 700 | 1 | |a Alexandru, M |e verfasserin |4 aut | |
| 700 | 1 | |a Papon, J F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European annals of otorhinolaryngology, head and neck diseases |d 2010 |g 140(2023), 2 vom: 01. März, Seite 65-69 |w (DE-627)NLM201398648 |x 1879-730X |7 nnns |
| 773 | 1 | 8 | |g volume:140 |g year:2023 |g number:2 |g day:01 |g month:03 |g pages:65-69 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.anorl.2022.08.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 140 |j 2023 |e 2 |b 01 |c 03 |h 65-69 | ||